IL4 and chronic kidney disease: Since two independent studies suggested increased numbers of ILC2s and type 2 cytokines (IL-4, IL-5, IL-13) in the peripheral blood of patients suffering from CKD due to type 2 diabetes (45, 46), it can be speculated that ILC2s might be a marker for renal fibrosis in human CKD.